marijuana stocks

Reliq Health Technologies Announces Receipt of Second Hardware Shipment

Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company that develops innovative mobile health (mHealth) and telemedicine solutions for the Community-Based Healthcare market, is pleased to announce that it has received the second shipment of backordered Remote Monitoring devices. The final shipments will be delivered by the end of October.

“We are pleased to announce that we have received another shipment of Remote Monitoring devices,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Now that we’re through the slower summer months we are gearing up for a very busy Fall season.  We continued to onboard new patients over the summer despite the hardware shortage through mid-July, client vacation schedules and the usual summer doldrums.  We look forward to ramping up onboarding significantly now that the slow season is behind us.”

Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market.  Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare.   The iUGO Care platform integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery.  iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

For further information contact:

Investor Relations at Reliq Health at 1-888-701-6390 or IR@reliqhealth.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws.  All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.

We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the “Company“) does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Jushi Holdings Inc. (JUSHF) Announces Participation in Upcoming Conferences and Events

Jushi Holdings Inc. Announces Participation in Upcoming Conferences and Events in September…

Cara Therapeutics, Inc. (CARA) Doses First Patient in Phase 1 Study of Oral CR845

Cara Therapeutics Doses First Patient in Phase 1 Study of Oral CR845…

$NEWC: Sannabis to Work With CORPROPAZ to Develop #Hemp Projects in Colombia

New Colombia Resources’ Sannabis to Work With CORPROPAZ to Develop Hemp Projects…

Aurora Cannabis Inc. (ACBFF) to File Dissident Circular Against Proposed CanniMed-Newstrike Combination

Aurora Cannabis to File Dissident Circular Against Proposed CanniMed-Newstrike Combination Proposed Transaction…